Interleukin-2 Receptor Blocking Antibody [EPC] - N0000175622

Pharmacologic Class Information

Pharmacologic Code N0000175622
Pharmacologic Name Interleukin-2 Receptor Blocking Antibody
Pharmacologic Uses
  • interleukin-2 receptor blocking antibody
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Interleukin-2 Receptor Blocking Antibody

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Interleukin-2 Receptor Blocking Antibody [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0331Simulect Non-Proprietary Name: BasiliximabInjection, Powder, For SolutionIntravenousNovartis Pharmaceuticals CorporationACTIVE
0078-0393Simulect Non-Proprietary Name: BasiliximabInjection, Powder, For SolutionIntravenousNovartis Pharmaceuticals CorporationACTIVE